Performance analysis of Alzamend Neuro (ALZN)
Annual Return
Over the past 3 years, ALZN has had an average annual return of -85.98%, underperforming the benchmark SPY, which returned +19.31% annual.
Over the past 5 years, ALZN has had an average annual return of -81.23%, underperforming the benchmark SPY, which returned +12.55% annual.
Since Jun 15, 2021, ALZN has had an average annual return of -83.58%, underperforming the benchmark SPY, which returned +13.15% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| +0% | -83.33% | -86.36% | -89.47% | -70.29% | -85.93% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | |||||
| 2025 | +0% | -33.33% | +25% | -40.00% | -33.33% | +0% | -50.00% | +0% | +0% | +0% | +0% | +0% | -83.33% |
| 2024 | -4.55% | +7.14% | +8.89% | -28.57% | -17.14% | -34.48% | -5.26% | -33.33% | -33.33% | +0% | -25.00% | +0% | -86.36% |
| 2023 | +17.70% | -19.11% | -20.85% | +28.57% | +32.84% | -29.74% | -11.11% | -42.26% | -9.28% | -51.14% | -30.23% | -26.67% | -89.47% |
| 2022 | -19.47% | -22.86% | +4.23% | -17.01% | -7.80% | -8.18% | +2.97% | +1.67% | +31.49% | -1.59% | -1.73% | -50.94% | -70.29% |
| 2021 | -35.26% | -49.37% | -30.84% | +0.62% | -30.51% | +0% | -11.23% | -85.93% |
Drawdown analysis of Alzamend Neuro (ALZN)
The maximum drawdown for the ALZN was -99.99%, occurring on Jul 29, 2025. This drawdown has not yet recovered.
The current ALZN drawdown is -99.99%.
Since Jun 15, 2021 ALZN has experienced the following drawdowns:
- 50% or more: 1 time
- 40% or more: 1 time
- 30% or more: 1 time
- 20% or more: 1 time
- 10% or more: 1 time
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.99% | Jun 15, 2021 | 1034 | Jul 29, 2025 | Ongoing | Ongoing | Ongoing |